Stadtlanders Pharmacy

CDC HIV/STD/TB Prevention News Update

Thursday, January 13, 2000
The CDC National Center for HIV, STD, and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases, and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Peer-Review Headlines

General Meadia


Peer-Review Headlines

Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection

Journal of the American Medical Association (01/05/00) Vol. 283, No. 1, P. 74; Sulkowski, Mark S.; Thomas, David L.; Chaisson, Richard E; et al.
Because the use of antiretroviral drugs in treating HIV can cause hepatotoxicity, researchers evaluated the effects of the drugs in people with hepatitis C or B virus and attempted to determine which drug combinations were more likely to cause such liver problems. The study included 298 patients who started new antiretroviral therapy between January 1996 and January 1998, with 71 percent receiving protease inhibitors. The other patients received dual nucleoside analog regimens. Of the two groups, chronic hepatitis C and B virus infection was found in 52 percent of the protease inhibitor group and 2.7 percent of the those receiving nucleoside analog drugs. Overall, severe hepatotoxicity was seen in about 10 percent of the patients. Of these 31 individuals, all but six stopped therapy. The researchers concluded that hepatotoxicity occurs in association with antiviral treatment, but the risk was greater for patients taking ritonavir. The risks for nelfinavir, indinavir, and nucleoside analog regimens were similar, and no deaths were associated with the toxicity. The authors conclude that antiretroviral therapies should be given to HIV-infected people who also are infected with hepatitis B or hepatitis C.


General Media

U.S. Funds Sought to Eradicate Tuberculosis

"U.S. Funds Sought to Eradicate Tuberculosis" USA Today (01/13/00) P. 9D; Manning, Anita
U.S. Rep. Sherrod Brown (D-Ohio) announced Wednesday that he will co-sponsor legislation to increase the budget for international tuberculosis (TB) control from $25 million in 1999 to $100 million. In making his announcement, Brown noted, "TB will kill at least 2 million people this year, more than any other year in history." He added, however, that if preventive measures are not taken, over 70 million people worldwide could die from the disease during the next 20 years, with nearly 1 billion more infected. Werner Christie, head of the Stop TB Initiative, a global partnership of health agencies, government health leaders, and advocacy groups, also said that political will is needed to provide poorer countries with drugs to fight the disease. The Stop TB steering committee will meet this week to set an agenda for an upcoming meeting in Amsterdam.

New AIDS Funding Announced

Boston Globe Online (01/13/00)
A nearly $12.5 million grant provided in part by the Ryan White CARE Act will provide funding for HIV/AIDS services in the Boston area. This year's funding is $1.8 million more than last year's grant. U.S. Sen. Edward Kennedy (D-Mass.), one of the two key sponsors of the Ryan White CARE Act of 1990, noted that the measure will be before Congress for extension this year and he will push to have it continue.

Teen Birthrate Takes a Big Toll in Brazil

"Teen Birthrate Takes a Big Toll in Brazil" Washington Post (01/13/00) P. A13; Buckley, Stephen
The birthrate among teenagers in Brazil has soared, even as commercials and clinics support birth control methods and provide condoms. Programs designed to reduce the number of pregnancies have seen little success as the media and the annual Carnaval party send mixed messages about sex to teens. Between 1993 and 1998, the birthrate for girls aged 15 to 19 increased 19 percent. About 40 percent of pregnant teens leave school, making pregnancy prevention a chief priority for the Health Ministry. Brazil's teenagers are also having sex earlier, many at age 12 or 13. They agree that television has an immense impact on their lives, as many forego relationships in place of quick sexual encounters called ficars. The ficar, a verb meaning "to stay" in Portugese, has evolved from kissing and hugging to a short sexual episode with near strangers. Men seem to have control over ficars, and they often oppose using condoms.

West Virginia School Battles TB Outbreak

Reuters (01/12/00)
A school bus driver with active tuberculosis (TB) has apparently infected up to 30 students in West Virginia with TB, but none of the children have the active form of the disease. Health officials note that about 700 students in the Kanawha County School District must be tested and re-tested for the disease throughout the semester. Children who test positive for TB will receive preventive antibiotics to reduce their chances of developing active TB.

Tests Find No Active TB Aboard Ship

Mobile Register Online (01/13/00); Helms, Jean Lakeman
Alabama health officials announced Wednesday that there is no sign of active tuberculosis (TB) in the crew of the cargo ship Birknes, which was stopped when a crew member who was put ashore in the Bahamas was diagnosed with active TB. The 20 crew members of the Cypriot ship, which was en route to France with a 20,000-ton shipment of soybeans, were voluntarily quarantined while health officials conducted skin tests and chest X-rays on them. The Mobile County Health Department was alerted to the threat by the Centers for Disease Control and Prevention, and the ship made port in Mobile on Tuesday.

HIV-Infected Drug Users Less Likely to Receive HAART

Reuters Health Information Services (01/12/00)
Research by the EuroSIDA Study Group suggests that HIV-infected intravenous drug users are 27 percent less likely to receive highly active antiretroviral therapy (HAART) than other HIV exposure groups. The scientists, who evaluated more than 6,600 HIV patients, also found that the drug users responded to the treatment similarly to other groups of patients. The researchers found no differences in the likelihood of receiving HAART in homosexual versus heterosexual subjects. The findings, published in the Journal of Acquired Immune Deficiency Syndromes (1999;22:369-378), suggest that drug users with HIV may have a worse prognosis and more AIDS-related illnesses if they continue to receive HAART less often than other groups.

Nigerian President Takes Charge of Anti-AIDS Campaign

PANA Wire Service (01/12/00)
Nigeria has formed a new committee, led by President Olusegum Obasanjo, that will coordinate all activities of the country's HIV/AIDS campaign. According to a spokesman, the new body was formed to fulfill the president's promise to increase public awareness about AIDS and to provide official commitment to fighting the epidemic. Statistics show that more than 29,000 Nigerians have died from AIDS since 1986.

Talking Clock With Anti-AIDS Message

"Talking Clock With Anti-AIDS Message" PANA Wire Service (01/12/00)
In the Kenyan town of Kisumu, provincial commissioner Peter Raburu is using an "anti-AIDS talking clock," which plays HIV prevention messages in many languages every hour for students. Kisumu, located in the western part of the country, has the highest HIV prevalence rate in Kenya. Raburu believes the clock will help to educate students about the disease, particularly in rural areas. The commissioner also suggested that the clock, invented by Kenyan Morgan Odhiambo, will help to reduce the costs involved in organizing anti-AIDS campaigns.

stadtlander.com: HOME | HIV | BACK